Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione-Reference-Cited by-同舟云学术

Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione

Published:2012-02-13 Issue:3 Volume:73 Page:428-436
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Lacut Karine,Ayme-Dietrich Estelle,Gourhant Lenaick,Poulhazan Elise,Andro Marion,Becquemont Laurent,Mottier Dominique,Le Gal Gregoire,Verstuyft Celine

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.04095.x/fullpdf

Reference25 articles.

1. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients;Pirmohamed;BMJ,2004

2. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin;D'Andrea;Blood,2005

3. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen;Sconce;Blood,2005

4. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose;Rieder;N Engl J Med,2005

5. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis;Sanderson;Genet Med,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

2. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

3. Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity;Life Science Alliance;2022-05-30

4. Significance of CYP4F2 polymorphism on oral anticoagulation therapy with acenocoumarol in South Indian patients with mechanical heart valves;Meta Gene;2019-06

5. Vitamin K antagonists and emergencies;European Journal of Emergency Medicine;2018-12